HIGHLIGHTS
- who: Shirley Lewis from the guidelines [16, , ]However, SBRT is applicable in HCC with recently published American Society of Radiation Oncology (ASTRO) guidelines formalising potential treatmentSBRT in neoadjuvant setting, bridge to transplant The standard curative option in early-stage HCC is liver transplantation. While only a few patients are eligible for transplant, many will have a long wait for a donor liver and run the risk of dropping off the list because of disease progression. AASLD rec>, months, and ommends bridging therapy when waiting time is, patients are often considered for the same when listed [50]. The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.